SBIR Phase II: Advancing an Interactive Learning Platform by Integrating Multiplayer Game Technology

这个小企业创新研究（SBIR）二期项目通过整合多人游戏技术，推进了Syandus的互动学习平台。Syandus目前的交互式交付平台允许制药公司和内容专家通过交互式演示、讨论组或自主学习向医生和患者传达复杂的概念。这个提议的项目增加了网络协作功能，为用户和内容专家之间的交互创造了机会，而不受地理限制。将多人游戏技术整合到Syandus的平台中，需要对该技术进行创新应用，以达到新的目的。该提案将支持修改现有平台以在协作设置中发挥作用，构建协作引擎以在用户之间同步应用程序数据，集成第三方多人网络解决方案以及开发原型应用程序以测试协作功能。Syandus已与全球前20大制药公司中的几家完成了基于现有平台的创新医学教育产品交付项目。在这个概念衍生的第一个商业应用程序中，医生将能够与全国范围内的内容专家远程连接，以一种比目前更引人注目的方式交互式地学习最新的最佳实践和医学科学。制药行业致力于通过国际和国家层面的思想领袖、地区医生思想领袖、执业医生及其患者之间的信息梯级交流医学科学创新和新的治疗方法。拟议概念的预期结果将成为制药公司的学习工具，允许全国的医生团体就疾病状态和适当的治疗进行互动对话。从长远来看，在教育领域，Syandus的技术可以用于开发更复杂的协作学习环境，使学生无论地理位置如何，都可以聚集在一个虚拟的生物世界或系统中（如细胞或器官），并以个人或团体的形式共同解决问题并优化过程。通过协作网络，加上引人注目的视觉效果、丰富的交互性和数学模型的潜在智能，可以通过信息和思想的自由交流创造出高度有益的学习体验。将Syandus的现有平台改造为具有多用户功能的平台，将丰富的人机交互添加到远程学习过程中，使科学模型栩栩如生，并允许更多的知识传播。

This Small Business Innovation Research (SBIR)Phase II project advances Syandus's interactive learning platform by integrating multiplayer game technology. Syandus's current interactive delivery platform allows pharmaceutical firms and content experts to communicate complex concepts to physicians and patients through interactive presentations, discussion groups or self-directed learning. The addition of network-enabled collaboration afforded by this proposed project creates the opportunity for interaction between users and content experts without the constraints of geography. The integration of multiplayer game technology into Syandus's platform requires the innovative application of this technology to serve a new purpose. This proposal will support modification of the existing platform to function in a collaborative setting, building a collaborative engine to synchronize application data between users, integration of a third party multiplayer networking solution and development of a prototype application to test collaborative functionality. Syandus has completed projects with several of the top 20 pharmaceutical companies for the delivery of innovative medical education products based on the existing platform. In the first business application derived from this proposed concept, physicians will be able to remotely connect with nationwide content experts to interactively learn the latest best practices and medical science in a more compelling way than currently available.The pharmaceutical industry strives to communicate medical science innovation and new treatment methods through an information cascade from international and national level thought leaders, to regional physician thought leaders, to practicing physicians and their patients. The anticipated results from the proposed concept will be a learning tool for pharmaceutical companies that allow groups of physicians nationwide to have an interactive dialog about a disease state and appropriate treatment. Longer term, in the educational realm, Syandus's technology could be used to develop more sophisticated collaborative learning environments that allow students, regardless of geographical location, to assemble in a virtual biological world or system (such as a cell or organ) and work together as individuals or in groups to solve problems and optimize processes. A highly rewarding learning experience can be created through the free exchange of information and ideas enabled by a collaborative network coupled with compelling visuals, rich interactivity and the underlying intelligence of mathematical models. Transforming Syandus's existing platform with multi user capability adds rich human interaction into the remote learning process, brings scientific models to life, and allows greater dissemination of knowledge.